Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation

Kun Yong Kim, Ahmi Baek, Ji Eun Hwang, Yeon A. Choi, Joon Jeong, Myeong Sok Lee, Dea Ho Cho, Jong Seok Lim, Keun Il Kim, Young Yang

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Low serum levels of adiponectin are a high risk factor for various types of cancer. Although adiponectin inhibits proliferation and metastasis of breast cancer cells, the underlying molecular mechanisms remain obscure. In this study, we show that adiponectin-activated AMPK reduces the invasiveness of MDA-MB-231 cells by stimulating dephosphorylation of AKT by increasing protein phosphatase 2A (PP2A) activity. Among the various regulatory B56 subunits, B56& gammal was directly phosphorylated by AMPK at Ser 298 and Ser 336, leading to an increase of PP2A activity through dephosphorylation of PP2Ac at Tyr 307. We also show that both the blood levels of adiponectin and the tissue levels of PP2A activity were decreased in breast cancer patients and that the direct administration of adiponectin into tumor tissues stimulates PP2A activity. Taken together, these findings show that adiponectin, derived from adipocytes, negatively regulates the invasiveness of breast cancer cells by activating the tumor suppressor PP2A.

Original languageEnglish
Pages (from-to)4018-4026
Number of pages9
JournalCancer Research
Volume69
Issue number9
DOIs
Publication statusPublished - 2009 May 1

Fingerprint

Protein Phosphatase 2
AMP-Activated Protein Kinases
Adiponectin
Breast Neoplasms
Tumor Suppressor Proteins
Adipocytes
Neoplasms
Neoplasm Metastasis
Serum

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kim, Kun Yong ; Baek, Ahmi ; Hwang, Ji Eun ; Choi, Yeon A. ; Jeong, Joon ; Lee, Myeong Sok ; Cho, Dea Ho ; Lim, Jong Seok ; Kim, Keun Il ; Yang, Young. / Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. In: Cancer Research. 2009 ; Vol. 69, No. 9. pp. 4018-4026.
@article{b26520f3057b4179be18cc7872262143,
title = "Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation",
abstract = "Low serum levels of adiponectin are a high risk factor for various types of cancer. Although adiponectin inhibits proliferation and metastasis of breast cancer cells, the underlying molecular mechanisms remain obscure. In this study, we show that adiponectin-activated AMPK reduces the invasiveness of MDA-MB-231 cells by stimulating dephosphorylation of AKT by increasing protein phosphatase 2A (PP2A) activity. Among the various regulatory B56 subunits, B56& gammal was directly phosphorylated by AMPK at Ser 298 and Ser 336, leading to an increase of PP2A activity through dephosphorylation of PP2Ac at Tyr 307. We also show that both the blood levels of adiponectin and the tissue levels of PP2A activity were decreased in breast cancer patients and that the direct administration of adiponectin into tumor tissues stimulates PP2A activity. Taken together, these findings show that adiponectin, derived from adipocytes, negatively regulates the invasiveness of breast cancer cells by activating the tumor suppressor PP2A.",
author = "Kim, {Kun Yong} and Ahmi Baek and Hwang, {Ji Eun} and Choi, {Yeon A.} and Joon Jeong and Lee, {Myeong Sok} and Cho, {Dea Ho} and Lim, {Jong Seok} and Kim, {Keun Il} and Young Yang",
year = "2009",
month = "5",
day = "1",
doi = "10.1158/0008-5472.CAN-08-2641",
language = "English",
volume = "69",
pages = "4018--4026",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

Kim, KY, Baek, A, Hwang, JE, Choi, YA, Jeong, J, Lee, MS, Cho, DH, Lim, JS, Kim, KI & Yang, Y 2009, 'Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation', Cancer Research, vol. 69, no. 9, pp. 4018-4026. https://doi.org/10.1158/0008-5472.CAN-08-2641

Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. / Kim, Kun Yong; Baek, Ahmi; Hwang, Ji Eun; Choi, Yeon A.; Jeong, Joon; Lee, Myeong Sok; Cho, Dea Ho; Lim, Jong Seok; Kim, Keun Il; Yang, Young.

In: Cancer Research, Vol. 69, No. 9, 01.05.2009, p. 4018-4026.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation

AU - Kim, Kun Yong

AU - Baek, Ahmi

AU - Hwang, Ji Eun

AU - Choi, Yeon A.

AU - Jeong, Joon

AU - Lee, Myeong Sok

AU - Cho, Dea Ho

AU - Lim, Jong Seok

AU - Kim, Keun Il

AU - Yang, Young

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Low serum levels of adiponectin are a high risk factor for various types of cancer. Although adiponectin inhibits proliferation and metastasis of breast cancer cells, the underlying molecular mechanisms remain obscure. In this study, we show that adiponectin-activated AMPK reduces the invasiveness of MDA-MB-231 cells by stimulating dephosphorylation of AKT by increasing protein phosphatase 2A (PP2A) activity. Among the various regulatory B56 subunits, B56& gammal was directly phosphorylated by AMPK at Ser 298 and Ser 336, leading to an increase of PP2A activity through dephosphorylation of PP2Ac at Tyr 307. We also show that both the blood levels of adiponectin and the tissue levels of PP2A activity were decreased in breast cancer patients and that the direct administration of adiponectin into tumor tissues stimulates PP2A activity. Taken together, these findings show that adiponectin, derived from adipocytes, negatively regulates the invasiveness of breast cancer cells by activating the tumor suppressor PP2A.

AB - Low serum levels of adiponectin are a high risk factor for various types of cancer. Although adiponectin inhibits proliferation and metastasis of breast cancer cells, the underlying molecular mechanisms remain obscure. In this study, we show that adiponectin-activated AMPK reduces the invasiveness of MDA-MB-231 cells by stimulating dephosphorylation of AKT by increasing protein phosphatase 2A (PP2A) activity. Among the various regulatory B56 subunits, B56& gammal was directly phosphorylated by AMPK at Ser 298 and Ser 336, leading to an increase of PP2A activity through dephosphorylation of PP2Ac at Tyr 307. We also show that both the blood levels of adiponectin and the tissue levels of PP2A activity were decreased in breast cancer patients and that the direct administration of adiponectin into tumor tissues stimulates PP2A activity. Taken together, these findings show that adiponectin, derived from adipocytes, negatively regulates the invasiveness of breast cancer cells by activating the tumor suppressor PP2A.

UR - http://www.scopus.com/inward/record.url?scp=65949116390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949116390&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-2641

DO - 10.1158/0008-5472.CAN-08-2641

M3 - Article

C2 - 19366811

AN - SCOPUS:65949116390

VL - 69

SP - 4018

EP - 4026

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 9

ER -